Literature DB >> 7988622

Comparison of the effects of dilevalol and propranolol on systemic and regional haemodynamics in healthy volunteers at rest and during exercise.

E Bellissant1, D Annane, C Thuillez, J F Giudicelli.   

Abstract

The effects of single oral doses of dilevalol 400 mg and propranolol 80 mg on systemic and regional haemodynamics at rest and after sub-maximal exercise, were compared, in a placebo-controlled, randomised, double-blind, crossover study in 6 healthy male volunteers. At rest, as compared to placebo, neither dilevalol nor propranolol significantly affected arterial pressure and heart rate but, whereas propranolol decreased cardiac output (-27% at 2 h) and tended to increase total peripheral resistance, dilevalol tended to increase cardiac output and decreased total peripheral resistance (-7% at 2 h). Neither dilevalol nor propranolol affected brachial artery diameter. Propranolol tended to decrease brachial artery flow (-20% at 2 h) and to increase brachial vascular resistance (+25% at 2 h), but dilevalol did not and the brachial irrigation ratios did not change. Neither of the drugs affected carotid haemodynamics or plasma atrial natriuretic factor. Both drugs tended to decrease plasma renin activity, and dilevalol (+82% at 2 h) increased norepinephrine more than propranolol (+19% at 2 h). After exercise, dilevalol and propranolol produced similar falls in the induced increases in arterial pressure, heart rate and cardiac output, and had the same effects on regional haemodynamics, plasma renin activity and atrial natriuretic factor. Finally, dilevalol greatly increased plasma norepinephrine. We conclude that the beta 2-adrenoceptor agonist activity of dilevalol was clearly expressed at rest, thus inducing vasodilation and counteracting the beta-adrenoceptor blockade-induced negative chronotropic and inotropic effects. However, during sub-maximal exercise, only the beta-adrenoceptor antagonist activity of dilevalol was apparent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988622     DOI: 10.1007/BF00193476

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  35 in total

1.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

2.  Pulsed Doppler: diameter, blood flow velocity and volumic flow of the brachial artery in sustained essential hypertension.

Authors:  M E Safar; P A Peronneau; J A Levenson; J A Toto-Moukouo; A C Simon
Journal:  Circulation       Date:  1981-02       Impact factor: 29.690

3.  Arterial vasodilating profile and biological effects of pinacidil in healthy volunteers.

Authors:  C Thuillez; E Pussard; E Bellissant; C Richer; R Kechrid; J F Giudicelli
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

4.  Role of the Frank-Starling mechanism in maintaining cardiac output during increasing levels of treadmill exercise in beta-blocked normal men.

Authors:  M Bevilacqua; S Savonitto; E Bosisio; E Chebat; P L Bertora; M Sardina; G Norbiato
Journal:  Am J Cardiol       Date:  1989-04-01       Impact factor: 2.778

5.  Clinical pharmacology of dilevalol (I). Comparison of the pharmacokinetic and pharmacodynamic properties of dilevalol and labetalol after a single oral administration in healthy subjects.

Authors:  A Fujimura; K Ohashi; M Tsuru; A Ebihara; K Kondo
Journal:  J Clin Pharmacol       Date:  1989-07       Impact factor: 3.126

6.  Differentiation of hemodynamic, humoral and metabolic responses to beta 1- and beta 2-adrenergic stimulation in man using atenolol and propranolol.

Authors:  A A McLeod; J E Brown; C Kuhn; B B Kitchell; F A Sedor; R S Williams; D G Shand
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

7.  Effect of oral dilevalol on forearm circulation in essential hypertension.

Authors:  C Giannattasio; G Seravalle; B M Cattaneo; R Perondi; G Grassi; A Zanchetti; G Mancia
Journal:  J Cardiovasc Pharmacol       Date:  1992-03       Impact factor: 3.105

8.  Atrial natriuretic factor--a circulating hormone stimulated by volume loading.

Authors:  R E Lang; H Thölken; D Ganten; F C Luft; H Ruskoaho; T Unger
Journal:  Nature       Date:  1985 Mar 21-27       Impact factor: 49.962

9.  Epinephrine and norepinephrine are cleared through beta-adrenergic, but not alpha-adrenergic, mechanisms in man.

Authors:  P E Cryer; R A Rizza; M W Haymond; J E Gerich
Journal:  Metabolism       Date:  1980-11       Impact factor: 8.694

10.  The pharmacodynamics of dilevalol.

Authors:  J G Riddell
Journal:  J Hum Hypertens       Date:  1990-06       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.